Researchers from the University of Melbourne have received a 3.5 million grant (US$2.51 million) from the Australian Cancer Research Council (ACRF) for the foundation’s new program investigating cancer cells singularly for better patient treatment and causes of treatment resistance. “This important investment from ACRF will enable us to gain a deeper understanding of how cancers develop at a single-cell level,” said Prof. Andrews Roberts, one of the study’s lead researchers said on March 15. He said that the funding will lead the team to “breakthroughs” in personalising cancer therapy and improving treatment responses and overcoming treatment resistance. “Though every year we’re getting a little bit better at treating cancers across the board, slowest progress has been made in the toughest cancer,” Roberts told Channel Seven’s Sunrise program. Excluding non-melanoma skin cancer, Australia’s most common cancers are prostate cancer, breast cancer, bowel cancer, skin cancer and lung cancers. These cancers make up …